Lanean...
Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
Women with BRCA mutations, who choose to decline or defer risk-reducing mastectomy, require a highly sensitive breast screening regimen they can begin by age 25 or 30. Meta-analysis of multiple observational studies, in which both mammography and magnetic resonance imaging (MRI) were performed annua...
Gorde:
| Argitaratua izan da: | Cancers (Basel) |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
MDPI
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6315500/ https://ncbi.nlm.nih.gov/pubmed/30513626 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers10120477 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|